Sanofi
SNY
$52.76
$0.440.84%
NASDAQ
| 12/31/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 7.82B | 7.28B | -- | 9.75B | |
| Total Receivables | 11.00B | 9.43B | -- | 12.20B | |
| Inventory | 9.76B | 11.37B | -- | 10.68B | |
| Prepaid Expenses | 926.60M | -- | -- | 848.90M | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | 14.57B | 4.15B | -- | 413.40M | |
| Total Current Assets | 44.09B | 32.23B | -- | 33.90B | |
|
|
|||||
| Total Current Assets | 44.09B | 32.23B | -- | 33.90B | |
| Net Property, Plant & Equipment | 12.01B | 12.73B | -- | 13.06B | |
| Long-term Investments | 44.92B | 53.66B | -- | 54.61B | |
| Goodwill | 44.92B | 53.66B | -- | 54.61B | |
| Total Other Intangibles | 14.76B | 19.42B | -- | 20.21B | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | 18.33B | 18.16B | -- | 15.06B | |
| Total Assets | 137.49B | 139.03B | -- | 139.79B | |
|
|
|||||
| Total Accounts Payable | 7.82B | 7.96B | -- | 8.10B | |
| Total Accrued Expenses | 2.45B | -- | -- | 2.76B | |
| Short-term Debt | 207.06M | 7.68B | -- | 224.38M | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | 4.43B | 2.51B | -- | 2.34B | |
| Total Finance Division Other Current Liabilities | 15.29B | 14.01B | -- | 13.33B | |
| Total Other Current Liabilities | 15.29B | 14.01B | -- | 13.33B | |
| Total Current Liabilities | 30.19B | 32.17B | -- | 26.76B | |
|
|
|||||
| Total Current Liabilities | 30.19B | 32.17B | -- | 26.76B | |
| Long-Term Debt | 12.21B | 13.40B | -- | 15.86B | |
| Short-term Debt | 207.06M | 7.68B | -- | 224.38M | |
| Capital Leases | 1.70B | 1.86B | -- | 1.94B | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | 12.78B | 13.39B | -- | 13.05B | |
| Total Liabilities | 56.88B | 60.81B | -- | 57.60B | |
|
|
|||||
| Common Stock & APIC | 2.62B | 3.05B | -- | 3.14B | |
| Retained Earnings | -- | -- | -- | -- | |
| Treasury Stock & Other | 77.63B | 74.83B | -- | 78.70B | |
| Total Common Equity | 80.24B | 77.88B | -- | 81.84B | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | -- | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | |
|
|
|||||
| Total Common Equity | 80.24B | 77.88B | -- | 81.84B | |
| Total Preferred Equity | -- | -- | -- | -- | |
| Total Minority Interest | 362.36M | 328.94M | -- | 345.97M | |
| Total Equity | 80.61B | 78.21B | -- | 82.19B | |
|
|
|||||